DOI:
10.1055/s-00000144
Zeitschrift für Orthomolekulare Medizin
LinksClose Window
References
Cukierman-Yaffe T, Bosch J, Diaz R et al.
Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
Lancet Diabetes Endocrinol 2014;
2: 562-572
We do not assume any responsibility for the contents of the web pages of other providers.